JobCubby JobCubby
Sign up
Immatics

Immatics

The Global Leader in Precision Targeting of PRAME

LinkedIn
Location
—
Roles tracked
0
In pipeline
0
Tracking since
—

At a glance

You're tracking 0 roles at Immatics. Track a role to start building momentum here.

Company intel

From the job board · LinkedIn data via posting sync
Industry
Biotechnology Research
Company size
648 people
Headquarters
Tuebingen +2 more
Founded
2000
Type
Public Company
Total funding
$1.0B

Immatics is committed to making a meaningful impact on the lives of patients with cancer. We are the global leader in precision targeting of PRAME, a target expressed in more than 50 cancers. Our cutting-edge science and robust clinical pipeline form the broadest PRAME franchise with the most PRAME indications and modalities, spanning TCR T-cell therapies and TCR bispecifics. Read more about Immatics on our homepage: https://immatics.com/ Find us also on: Instagram: https://www.instagram.com/immatics/ YouTube: https://www.youtube.com/channel/UCv7uTpsGXvSNzwSX_xOtYSA Legal notice: https://immatics.com/imprint/

Discovery of HLA-restricted tumor-associated peptides as cancer targets Biomarkers Immunomonitoring Peptidomics & mass spectrometry Standardized PBMC collection Bioinformatics Immunology TCR Discovery Bispecific Development TCR-based Immunotherapies Adoptive Cell Therapy TCR Bispecifics
1 open role at Immatics on the job board

Open roles at Immatics